Achieve Clinical Research LLC d/b/a Accel Research Sites — Birmingham, Alabama

Achieve Clinical Research LLC d/b/a Accel Research Sites is a clinical research site located in Birmingham, Alabama, United States 35216.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Achieve Clinical Research LLC d/b/a Accel Research Sites has participated in 2 clinical trials.

Therapeutic areas: Respiratory Syncytial Virus Infections, COVID-19 Disease.

Sponsors: Bavarian Nordic.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Achieve Clinical Research LLC d/b/a Accel Research Sites?

Achieve Clinical Research LLC d/b/a Accel Research Sites has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Achieve Clinical Research LLC d/b/a Accel Research Sites conducted?

Achieve Clinical Research LLC d/b/a Accel Research Sites has 2 clinical trials on record. Their work covers Respiratory Syncytial Virus Infections, COVID-19 Disease.

Is Achieve Clinical Research LLC d/b/a Accel Research Sites accredited by Crixeo Clinical Trials?

Achieve Clinical Research LLC d/b/a Accel Research Sites has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Achieve Clinical Research LLC d/b/a Accel Research Sites?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.